These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 24451645)

  • 1. Inhibition of PDZ domain-mediated interactions.
    Grillo-Bosch D; Choquet D; Sainlos M
    Drug Discov Today Technol; 2013 Dec; 10(4):e531-40. PubMed ID: 24451645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational Design of PDZ Domain Inhibitors: Discovery of Small Organic Compounds Targeting PDZ Domains.
    Hoffer L; Roche P; Morelli X
    Methods Mol Biol; 2021; 2256():277-289. PubMed ID: 34014528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caged mono- and divalent ligands for light-assisted disruption of PDZ domain-mediated interactions.
    Sainlos M; Iskenderian-Epps WS; Olivier NB; Choquet D; Imperiali B
    J Am Chem Soc; 2013 Mar; 135(12):4580-3. PubMed ID: 23480637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elucidation of the binding preferences of peptide recognition modules: SH3 and PDZ domains.
    Teyra J; Sidhu SS; Kim PM
    FEBS Lett; 2012 Aug; 586(17):2631-7. PubMed ID: 22691579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PDZ domain-mediated protein interactions: therapeutic targets in neurological disorders.
    Khan Z; Lafon M
    Curr Med Chem; 2014; 21(23):2632-41. PubMed ID: 24606518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small molecule protein-protein interaction inhibitors as CNS therapeutic agents: current progress and future hurdles.
    Blazer LL; Neubig RR
    Neuropsychopharmacology; 2009 Jan; 34(1):126-41. PubMed ID: 18800065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structures and target recognition modes of PDZ domains: recurring themes and emerging pictures.
    Ye F; Zhang M
    Biochem J; 2013 Oct; 455(1):1-14. PubMed ID: 24028161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Making protein interactions druggable: targeting PDZ domains.
    Dev KK
    Nat Rev Drug Discov; 2004 Dec; 3(12):1047-56. PubMed ID: 15573103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligand binding by PDZ domains.
    Chi CN; Bach A; Strømgaard K; Gianni S; Jemth P
    Biofactors; 2012; 38(5):338-48. PubMed ID: 22674855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular Delivery of Peptidyl Ligands by Reversible Cyclization: Discovery of a PDZ Domain Inhibitor that Rescues CFTR Activity.
    Qian Z; Xu X; Amacher JF; Madden DR; Cormet-Boyaka E; Pei D
    Angew Chem Int Ed Engl; 2015 May; 54(20):5874-8. PubMed ID: 25785567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subtype-specific roles of phospholipase C-β via differential interactions with PDZ domain proteins.
    Kim JK; Lim S; Kim J; Kim S; Kim JH; Ryu SH; Suh PG
    Adv Enzyme Regul; 2011; 51(1):138-51. PubMed ID: 21035486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The emerging contribution of sequence context to the specificity of protein interactions mediated by PDZ domains.
    Luck K; Charbonnier S; Travé G
    FEBS Lett; 2012 Aug; 586(17):2648-61. PubMed ID: 22709956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural diversity of PDZ-lipid interactions.
    Gallardo R; Ivarsson Y; Schymkowitz J; Rousseau F; Zimmermann P
    Chembiochem; 2010 Mar; 11(4):456-67. PubMed ID: 20091728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The binding affinities of proteins interacting with the PDZ domain of PICK1.
    Bolia A; Gerek ZN; Keskin O; Banu Ozkan S; Dev KK
    Proteins; 2012 May; 80(5):1393-408. PubMed ID: 22275068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chemical libraries dedicated to protein-protein interactions].
    Sperandio O; Villoutreix BO; Morelli X; Roche P
    Med Sci (Paris); 2015 Mar; 31(3):312-9. PubMed ID: 25855285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Side-chain interactions form late and cooperatively in the binding reaction between disordered peptides and PDZ domains.
    Haq SR; Chi CN; Bach A; Dogan J; Engström Å; Hultqvist G; Karlsson OA; Lundström P; Montemiglio LC; Strømgaard K; Gianni S; Jemth P
    J Am Chem Soc; 2012 Jan; 134(1):599-605. PubMed ID: 22129097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuronal PDZ domains: a promising new molecular target for inhaled anesthetics?
    Tao YX; Johns RA
    Mol Interv; 2004 Aug; 4(4):215-21. PubMed ID: 15304557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An allosteric intramolecular PDZ-PDZ interaction modulates PTP-BL PDZ2 binding specificity.
    van den Berk LC; Landi E; Walma T; Vuister GW; Dente L; Hendriks WJ
    Biochemistry; 2007 Nov; 46(47):13629-37. PubMed ID: 17979300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The structural flexibility of the shank1 PDZ domain is important for its binding to different ligands.
    Lee JH; Park H; Park SJ; Kim HJ; Eom SH
    Biochem Biophys Res Commun; 2011 Apr; 407(1):207-12. PubMed ID: 21376703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery, structure-activity relationship studies, and crystal structure of nonpeptide inhibitors bound to the Shank3 PDZ domain.
    Saupe J; Roske Y; Schillinger C; Kamdem N; Radetzki S; Diehl A; Oschkinat H; Krause G; Heinemann U; Rademann J
    ChemMedChem; 2011 Aug; 6(8):1411-22. PubMed ID: 21626699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.